Market Place
Sourcing Support
Nexstim Receives NBS System 5 Order from European Customer
02 Oct 2024 //
GLOBENEWSWIRE
Nexstim Receives Order for NBS System 5 in Finland
27 Sep 2024 //
GLOBENEWSWIRE
New European Customer Orders Nexstim NBS System 5
03 Sep 2024 //
GLOBENEWSWIRE
NEXSTIM PLC HALF-YEAR REPORT JANUARY 1 – JUNE 30, 2024 (UNAUDITED)
16 Aug 2024 //
GLOBENEWSWIRE
Notice of Nexstim Plc’s Half-Year Report H1 2024
13 Aug 2024 //
GLOBENEWSWIRE
Nexstim Receives NBS System 5 Order from New European Customer
10 Jul 2024 //
GLOBENEWSWIRE
US Customer Places Upgrade Order for Two Nexstim NBS 6 Systems
01 Jul 2024 //
GLOBENEWSWIRE
Nexstim has Agreed on a Digitalization and Loan with Finnvera
27 Jun 2024 //
GLOBENEWSWIRE
Nexstim Plc launches an unsecured convertible bond offering of up to EUR 750,000
25 Jun 2024 //
GLOBENEWSWIRE
Nexstim Plc Closes EUR 750,000 Convertible Bond Offering
25 Jun 2024 //
GLOBENEWSWIRE
Nexstim Plc: Major Holdings Disclosure As Per Finnish Securities Act
18 Jun 2024 //
GLOBENEWSWIRE
Nexstim: Disclosure Of Major Holdings Per Finnish Securities Markets Act
17 Jun 2024 //
GLOBENEWSWIRE
Nexstim Provides Further Details on Technology License Agreement with Magnus
12 Jun 2024 //
GLOBENEWSWIRE
Nexstim Plc: Disclosure of Major Holdings according to Chapter 9, Section 10
11 Jun 2024 //
GLOBENEWSWIRE
Distributor Orders Nexstim NBS System 5 for European Hospital
10 Jun 2024 //
GLOBENEWSWIRE
Nexstim, Sinaptica To Collaborate On Alzheimer`s Program
07 Jun 2024 //
GLOBENEWSWIRE
Finnish Hospital Orders Nexstim NBS System 5
08 May 2024 //
GLOBENEWSWIRE
Health Canada Approves Nexstim NBS 6 For MDD Treatment
06 May 2024 //
GLOBENEWSWIRE
Nexstim, Inomed In Strategic Alliance For US Market
03 May 2024 //
GLOBENEWSWIRE
Neurosurgery Customer from Germany Orders Nexstim NBS System 5
26 Apr 2024 //
GLOBENEWSWIRE
Nexstim Plc Business Update Q1 2024
26 Apr 2024 //
GLOBENEWSWIRE
Smart for Life: White Paper on Nutraceuticals Industry
26 Apr 2024 //
GLOBENEWSWIRE
Nexstim Plc: Managers™ Transactions, Niemist¶
25 Apr 2024 //
GLOBENEWSWIRE
Nexstim Plc: Managers™ Transactions, Weckroth
25 Apr 2024 //
GLOBENEWSWIRE
Nexstim Plc: Managers™ Transactions, Forss
25 Apr 2024 //
GLOBENEWSWIRE
Nexstim Plc: Managers™ Transactions, Hild©n
25 Apr 2024 //
GLOBENEWSWIRE
Nexstim Receives NBS 6 System Order from Clinic in Florida, US
22 Apr 2024 //
GLOBENEWSWIRE
Nexstim Resolves New Stock Option Plan 2024
12 Apr 2024 //
GLOBENEWSWIRE
Nexstim Plc: Resolutions of the Annual General Meeting of Shareholders
28 Mar 2024 //
GLOBENEWSWIRE
Nexstim Plc: Invitation to the Annual General Meeting
07 Mar 2024 //
GLOBENEWSWIRE
Nexstim Plc Publishes 2023 Annual Report
06 Mar 2024 //
GLOBENEWSWIRE
Nexstim Receives NBS System 5 Order from Neurosurgery Customer in Germany
28 Feb 2024 //
GLOBENEWSWIRE
NEXSTIM PLC™S FINANCIAL STATEMENTS BULLETIN 2023
27 Feb 2024 //
GLOBENEWSWIRE
Notice of Nexstim Plc™s 2023 Full Year Results
22 Feb 2024 //
GLOBENEWSWIRE
Nexstim Plc: Proposals of the Shareholder™s Nomination Board to the Meeting
31 Jan 2024 //
GLOBENEWSWIRE
Nexstim Receives NBS System 5 Order from Healthcare Services Group in the US
10 Jan 2024 //
GLOBENEWSWIRE
Insider Information, profit warning: Nexstim Oyj specifies its guidance for 2023
02 Jan 2024 //
GLOBENEWSWIRE
Nexstim receives Nexstim NBS System 5 order from Distributor in Europe
29 Dec 2023 //
GLOBENEWSWIRE
Nexstim Plc’s Financial Information in 2024 and Updated Disclosure Policy
22 Dec 2023 //
GLOBENEWSWIRE
Nexstim receives Nexstim NBS System 5 order from Europe for Neurosurgery Use
22 Dec 2023 //
GLOBENEWSWIRE
Nexstim Receives Order for Two NBS 6 Systems from Distributor
21 Dec 2023 //
GLOBENEWSWIRE
Nexstim Plc™s Financial Information in 2024 and Updated Disclosure Policy
21 Dec 2023 //
GLOBENEWSWIRE
Hospital in Germany Orders Nexstim NBS System 5
19 Dec 2023 //
GLOBENEWSWIRE
Nexstim Releases New System Functionalities for Research Use in Europe
04 Dec 2023 //
GLOBENEWSWIRE
Nexstim Plc Changes Certified Advisor to Carnegie Investment Bank AB (publ)
30 Nov 2023 //
GLOBENEWSWIRE
Nexstim Receives NBS System 6 Order from Hospital in United States
20 Nov 2023 //
GLOBENEWSWIRE
Nexstim Receives First Order for NBS 6 Therapy System in the United States
14 Nov 2023 //
GLOBENEWSWIRE
Nexstim Plc™s New Shares Have Been Registered in Trade Register
08 Nov 2023 //
GLOBENEWSWIRE
Nexstim Plc: Share subscriptions based on stock options 2020A
03 Nov 2023 //
GLOBENEWSWIRE
Nexstim Plc Business Update Q3 2023
27 Oct 2023 //
GLOBENEWSWIRE
Nexstim Has Won a Tender Process Resulting in a Procurement Decision
20 Oct 2023 //
GLOBENEWSWIRE
Nexstim Receives NBS System 5 Order in Europe
05 Oct 2023 //
GLOBENEWSWIRE
Nexstim Receives Order for NBS 5 System with NexSpeech®
26 Sep 2023 //
GLOBENEWSWIRE
Nexstim Delivers an NBS 5+ System to a New Customer for Neuroscience Use
23 Aug 2023 //
GLOBENEWSWIRE
Nexstim Plc Half-Year Report January 1 June 30, 2023 (Unaudited)
18 Aug 2023 //
GLOBENEWSWIRE
Notice of Nexstim Plc™s Half-Yearly Report H1 2023
14 Aug 2023 //
GLOBENEWSWIRE
Nexstim Plc agreed on a loan with Nordea to fund investments into growth
10 Aug 2023 //
GLOBENEWSWIRE
Nexstim Receives an NBS 5 System Order from a German Hospital
03 Aug 2023 //
GLOBENEWSWIRE
Nexstim Receives Order for NBS System 5 from Boston VA Hospital
31 Jul 2023 //
GLOBENEWSWIRE
